Syndax Pharmaceuticals, Inc. (SNDX)

24.31 -0.12 (-0.49%) USD  |  NASDAQ  |  Apr 15, 16:00
24.06 -0.25 (-1.03%) After-Hours: 20:00
More

Syndax Pharmaceuticals Research and Development Expense (Annual) : 258.78M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for SNDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Cogent Biosciences, Inc. 265.16M
Vera Therapeutics, Inc. 214.79M
Biogen, Inc. 1.481B
Johnson & Johnson 14.83B
Tango Therapeutics, Inc. 129.88M